Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
125 participants
INTERVENTIONAL
2020-10-01
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is good evidence that light therapy is an effective treatment option to improve mood in affective disorders.
The present study aims at investigating the psychophysiological effects of a 3-week morning bright light exposure in reducing stress and stress-related problems in students preparing for major exams.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurofeedback-mindfulness Techniques on Anxiety, Stress, and Academic Performance of Nursing Students
NCT07234006
Healing Light Algorithms for Nurses in the ICU
NCT05949827
Internet-based Stress Reduction Training for Students
NCT02062762
Relaxation Effects of Personalized Breathing Exercises for Healthy College Students
NCT06121596
Effectiveness of Heart Rate Variability Biofeedback Training Versus a Meditation Program in Reducing Stress Levels in University Undergraduate Students.
NCT06457932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Offering an effective treatment for stress-related symptoms in students is a challenge. In situations of intense stress, conventional methods such as relaxation and mindfulness-based programs often fail because of poor prior practice. Only a few students apply cognitive behavioral interventions. Although medication might decrease stress symptoms within days, the side effects of drugs cannot be ignored. Therefore, there is a need for effective and efficient treatment of acute stress symptoms in students.
Bright light therapy is an effective treatment for several mental disorders, e.g. affective disorders and sleep disorders. There is some evidence, that exposure to bright light may even reduce stress in patients with burnout symptoms. Thus, exposure to bright light may be a promising new option to reduce academic stress and improve mood and sleep parameters.
In the present study, a large-area desk lamp, which emits diffuse light and is controllable in its luminance and correlated color temperature is used. Study participants are randomly assigned to one of three study arms: (i) exposure to polychromatic light of 5,000 lux and 5,300 Kelvin, (ii) exposure to polychromatic light of 50 lux and 2,200 Kelvin, or (iii) no light intervention. Data collection takes place in winter periods.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
The control light condition comprises dim, reddish light. The reddish color tone in this light intervention should mask allocation to the study arm. A no-light intervention group (study arm 3) will be established as an additional control condition.
Data analysis will be carried out by a member of the project team who is blinded to study arm allocation.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bright white light intervention
exposure to 5,000 lux with polychromatic white light with 5,300 Kelvin at eye level; light exposure starts immediately after awakening; light exposure takes place on weekdays (Monday till Friday) over a period of 3 weeks
Bright light intervention
Exposure with 5,000 lux at eye level for one hour and a Correlated Color Temperature of 5,300 Kelvin every morning for three weeks.
dim reddish light intervention
exposure to 50 lux with polychromatic reddish light with 2,200 Kelvin at eye level; light exposure starts immediately after awakening; light exposure takes place on weekdays (Monday till Friday) over a period of 3 weeks
Reddish placebo light
Exposure with 50 lux at eye level for one hour and a Correlated Color Temperature of 2,200 Kelvin every morning for three weeks.
no light intervention
no light intervention takes place in the morning; the study participants follow their natural rhythm of life
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bright light intervention
Exposure with 5,000 lux at eye level for one hour and a Correlated Color Temperature of 5,300 Kelvin every morning for three weeks.
Reddish placebo light
Exposure with 50 lux at eye level for one hour and a Correlated Color Temperature of 2,200 Kelvin every morning for three weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* major exam at least 5 weeks ahead
* major depressive disorder (PHQ-9): Score \> 4
* possession of smartphone and data plan
Exclusion Criteria
* seasonal affective disorder (PIDS-A): Score \> 11
* taking medication which increases photo-sensitivity
* taking medication to increase cognitive performance
* starting or changing pharmacotherapy for affective disorders and anxiety disorders within the last two weeks
* changing of all kinds of medication within the last two weeks
* headache (PHQ-D, Item f): Rating "severly impaired"
* increased light sensitivity: Item "Wearing sunglasses outside on sunny days" is answered with 'often' or 'very often'
* currently undergoing psychotherapeutic treatment
* the presence of an eye disease for which light therapy is contraindicated
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bartenbach GmbH
UNKNOWN
Universitaet Innsbruck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Markus Canazei
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Markus Canazei, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Innsbruck
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Innsbruck
Innsbruck, Tyrol, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
878649
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.